Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Mastercard to Sell Nets Payments Unit Following $3.2 Billion Acquisition

The divestment follows Mastercard's strategic review of its portfolio.Highlights: Mastercard is set to sell its Nets payments unit.The...

Mastercard Seeks to Offload Payments Unit It Acquired for $32 Billion

The proposed sale comes as Mastercard re-evaluates its payments strategy.Highlights: Mastercard aims to sell its payments unit, originally...

US FTC Reports Consumers Lost $15.9 Billion to Fraud in 2025

The FTC reveals alarming fraud losses impacting millions of Americans.Highlights: Consumers lost $15.9 billion to fraud in 2025,...

EU, UK, and Switzerland Strengthen T1 Testing Plan for 2027 Transition

Three regions collaborate on testing ahead of joint financial move.Highlights: EU, UK, and Switzerland announce T1 testing plan.Collaboration...